On June 30, 2025, Regeneron Pharmaceuticals (NasdaqGS:REGN) was removed from multiple key indices, a development that may influence its investment appeal and stock liquidity. Over the last month ...

Regeneron stock (NASDAQ NDAQ: REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P500 index. This outperformance can be attributed to earlier-than-expected regulatory ...

These factors contributed to a robust return of 2.7% for the Russell 1000 Index, ... “Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) – the biggest loser in the book by absolute dollars.

On June 30, 2025, Regeneron Pharmaceuticals (NasdaqGS:REGN) was removed from multiple key indices, a development that may influence its investment appeal and stock liquidity. Over the last month, the ...